Taking place November 2-3, 2022 in Philadelphia, the 3rd Next-Gen MSL Excellence Summit empowers Medical Science Liaisons with all the scientific data tools and customer outreach skills they need to build successful relationships with all stakeholders. The faculty of industry leaders will help attendees refine their approach to Key Opinion Leaders and clearly, convincingly communicate it with patients throughout the product life cycle.
Registering for this event gains you an all-access pass to 3 programs in 1! Attendees can also learn and network in discussions and sessions from the 6th Digital Strategy & Innovation for Medical Affairs Summit or the 2nd Investigator-Initiated Trials Summit.
The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing b2b events.
Important topics of discussion:
- Discuss and analyze career opportunities and better horizons for MSLs
- Strategic planning for onboarding to offer the best experience to newbies
- Ways to successfully collaborate with cross-functional teams
- Learn unique ways of soft skill MSL management
- Innovative strategies for synchronizing medical affairs with clinical development and commercial teams
- Leverage emotional intelligence to engage KOLs, gather insights and relay scientific information
- Most effective ways to achieve success as an MSL
- Predict future trends for the optimum development and success of MSLs
- Discuss the role of MSL in voicing the patient’s opinion in research and development
MSLs need to learn effective presentation techniques in physical and virtual formats. To help with these needs, at this event industry experts will share tips on correct body language, proper conduct and effective communication skills to ensure that the MSLs engage with the audience.
Special fireside chats will cover ways to elevate the voice of the patient in R&D. Thought leaders will discuss how trauma-informed languages help in medical education as well as shared decision-making and best practices in patient-centric education. The discussions will involve the robust use of digital technology within the organization’s KOL strategy to optimize field engagement, advance scientific partnerships, and better clinical insights.
To learn more, please visit https://nnw.fm/GhN93.
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is part of the InvestorBrandNetwork
